What Really Happens During Menopause: Symptoms, Treatments, and How to Get the Care You Need

TLDR: Menopause spans 4-8 years of hormonal transition affecting 1.3 billion women worldwide. Symptoms range from hot flashes and brain fog to cardiovascular risks and mental health challenges. November 2025 FDA guidance confirms hormone therapy works safely when started within 10 years of menopause. Non-hormonal treatments prove equally effective. Three priorities matter most: understanding your symptoms, choosing evidence-based therapies, and advocating for comprehensive care. This guide provides the knowledge you need to navigate this transition with confidence.

You probably learned that menopause means your periods stop and you experience hot flashes for a while. The reality proves far more complex and consequential. Here’s what nobody tells you: menopause receives less than 0.1% of research funding despite affecting 1.3 billion women for a third of their lives. The pharmaceutical industry invested billions developing Viagra within years, yet women waited decades for hormone therapy guidance based on flawed studies. Menopause represents a multi-year transition where oestrogen and progesterone levels fluctuate wildly before declining permanently. This hormonal shift affects every body system—brain, heart, bones, mood, metabolism, and sexual function. Perimenopause typically begins in your 40s and lasts 4-8 years, with hormone levels swinging dramatically day to day and creating symptoms from annoying to life-disrupting. “The menopausal transition is a period of significant hormonal and psychosocial change,” explains research published in Menopause.[1] Despite this scale, menopause remains vastly underresearched, underdiscussed, and undertreated. Women report feeling dismissed by healthcare providers, unsupported by partners, and invisible in workplaces. The November 2025 FDA removal of black box warnings from hormone therapy marks a watershed moment, correcting 23 years of misleading guidance that left millions of women suffering unnecessarily. Understanding what happens during menopause, which treatments are effective, and how to advocate for yourself can transform this transition from a crisis into a manageable life stage.

Understanding Your Symptoms: What’s Actually Happening

Hot Flashes Signal Cardiovascular Changes

Hot flashes represent more than temporary discomfort—they function as early warning signals for cardiovascular health. Up to 80% of women experience vasomotor symptoms, with severity and duration varying tremendously.[2] When oestrogen levels drop, blood vessels lose their ability to regulate temperature efficiently. This triggers the sensation of intense heat, flushing, and sweating that can occur multiple times daily. Some women experience mild flashes for a few months; others endure severe symptoms for over a decade. Recent research from the American Heart Association reveals that frequent, severe hot flashes correlate with increased risk of heart disease and stroke years later.[3] The Study of Women’s Health Across the Nation (SWAN) tracked thousands of women and documented alarming changes in cholesterol, blood pressure, and metabolic markers during perimenopause—changes independent of chronological ageing. Consider a woman experiencing 10-15 hot flashes daily: she faces disrupted sleep, impaired work performance, social embarrassment, and potentially elevated cardiovascular risk. The takeaway? Track your hot flash frequency and severity, then discuss them with your doctor as part of a comprehensive cardiovascular risk assessment. Treating hot flashes addresses both quality of life and potentially long-term health outcomes.

Brain Fog Reflects Real Neurological Changes

Memory lapses, difficulty concentrating, and word-finding problems during perimenopause stem from actual neurological changes, not imagination. Oestrogen receptors densely populate brain regions governing memory, attention, and executive function. When oestrogen levels fluctuate during perimenopause, these neural systems temporarily destabilise.[4] Women describe walking into rooms and forgetting their purpose, losing track of conversations mid-sentence, or struggling to recall familiar words. These experiences feel qualitatively different from normal forgetfulness—sharper, more frequent, more distressing. Research shows cognitive function typically returns to baseline post-menopause once hormone levels stabilise, though the transition period can span years. A 48-year-old executive might find herself unable to recall key points during presentations despite having perfect recall months earlier. The fog creates professional anxiety and erodes confidence precisely when many women reach career peaks. Recent WHO-commissioned research provides reassurance: menopausal hormone therapy carries no increased dementia risk.[5] Your cognitive symptoms deserve validation and treatment, not dismissal as “normal ageing.” Discuss them explicitly with your healthcare provider and explore both hormonal and non-hormonal interventions.

Genitourinary Syndrome Creates Cascading Health Problems

Consider this: female executives earning six figures endure vaginal pain that disrupts their concentration during board meetings, yet feel unable to discuss it with colleagues. Professional athletes watch their performance decline from pelvic floor changes they never anticipated. Vaginal dryness, painful intercourse, urinary urgency, and recurrent infections affect 50-87% of postmenopausal women-yet fewer than 25% seek treatment.[6] Declining oestrogen causes vaginal tissue to thin, lose elasticity, and produce less lubrication. The medical term “genitourinary syndrome of menopause” replaced the older “vaginal atrophy” to reflect the full scope of symptoms. Beyond physical discomfort, these changes profoundly impact sexual function, intimate relationships, self-image, and daily activities. Dr. Francisca Molero Rodríguez, Director of the Iberoamerican Institute of Sexology, emphasises: “It is important to reach for these treatments in order to feel both physically and mentally good, as well as to consult on your sexual relationships, since most women regard sex and their sexual function as important.”[7] Hot flashes often improve spontaneously over time, but genitourinary symptoms typically worsen without intervention. A woman might avoid sexual intimacy due to pain, straining her relationship and increasing her sense of isolation. She might curtail social activities to stay near bathrooms due to urgency, gradually narrowing her world. The silence around these symptoms perpetuates suffering. Multiple effective treatments exist—local oestrogen, hyaluronic acid moisturisers, and other evidence-based options—with clinical trials showing 80-87% efficacy rates.[8] Start conversations about genitourinary symptoms early, before tissue changes become severe. Treatment works better when initiated proactively rather than reactively.

Choosing Evidence-Based Treatments: What Actually Works

Hormone Therapy Proves Safe Within the Timing Window

The November 2025 FDA removal of black box warnings from hormone therapy products corrects decades of misleading guidance that deterred millions from effective treatment. For 23 years, these warnings—the FDA’s most serious alert—created widespread fear among doctors and patients despite mounting evidence of safety when therapy begins early in the menopausal transition.[9] The 2002 Women’s Health Initiative study reported increased risks of breast cancer, heart disease, and stroke with hormone therapy, causing prescriptions to plummet overnight. Subsequent analysis revealed critical flaws: the study enrolled women averaging age 63 who started hormones more than a decade past menopause.[10] Timing matters enormously. Current evidence demonstrates hormone therapy works safely and effectively when initiated within 10 years of menopause onset or before age 60.[11] Dr. Stephanie Faubion, Medical Director for The Menopause Society, explains: “The findings suggest lower risk and potentially greater benefit of estrogen-based therapy when started in perimenopause.”[12] Consider a 49-year-old woman experiencing severe hot flashes and sleep disruption: starting hormone therapy now offers 80-95% symptom relief plus bone protection and possible cardiovascular benefits. Waiting until age 65 changes the risk-benefit profile significantly. Ask your doctor about the timing window and whether you qualify as a candidate for hormone therapy based on symptom severity, medical history, and personal preferences.

Non-Hormonal Options Deliver Real Results

Women pursuing natural approaches face a paradox: dismissal from doctors who consider non-pharmaceutical options unscientific, yet judgment from wellness communities claiming hormones are dangerous. The truth sits between these extremes. Effective alternatives to hormone therapy exist for women who have contraindications, prefer non-hormonal approaches, or want combination strategies. Multiple prescription medications reduce hot flash frequency by 50-60%, including SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), and gabapentin.[13] Cognitive behavioural therapy specifically designed for menopausal symptoms demonstrates effectiveness in clinical trials, reducing not just symptom frequency but also the distress symptoms caused. Evidence-based botanical compounds show promise: Luprenol (hop extract) achieves 95% efficacy after three months in reducing hot flashes, while Cimicifuga racemosa (black cohosh) improves both vasomotor symptoms and sleep quality.[14][15] For genitourinary symptoms, hyaluronic acid-based vaginal moisturisers work remarkably well, with clinical trials showing 80% efficacy rates and 87% of women experiencing relief from painful intercourse.[8] The American Urological Association’s 2025 guideline provides comprehensive recommendations for both hormonal and non-hormonal approaches to genitourinary syndrome.[16] Imagine a breast cancer survivor who needs to avoid oestrogen: she can combine an SNRI for hot flashes, hyaluronic acid moisturiser for vaginal dryness, and melatonin for sleep, achieving substantial symptom relief through non-hormonal means. Work with your healthcare provider to create a personalised treatment plan that addresses your specific symptom profile, medical history, and treatment preferences.

Lifestyle Interventions Form the Essential Foundation

Marathon runners suddenly notice they overheat during training. Yoga instructors experience joint pain that disrupts their practice. Tennis players lose stamina inexplicably. Active women assume declining performance signals ageing or laziness, rarely connecting it to menopause. Exercise, nutrition, stress management, and smoking cessation create the foundation upon which all other treatments build-and often restore performance that women assumed was permanently lost. Physical activity reduces hot flash frequency, improves sleep quality, maintains bone density, supports cardiovascular health, enhances mood, and helps manage weight.[17] The mechanism involves multiple pathways: exercise regulates thermoregulation, reduces inflammatory markers, supports neurotransmitter balance, and improves vascular function. Women who remain sexually active report fewer genitourinary symptoms, likely due to increased vaginal blood flow from mechanical stimulation. Mediterranean dietary patterns—emphasising vegetables, fruits, whole grains, fish, olive oil, and moderate red wine—protect cardiovascular health precisely when menopausal changes accelerate risk. The Spanish Menopause Society recommends specific vitamin D supplementation to prevent osteoporosis, as declining oestrogen affects calcium absorption and bone remodelling.[14] Mindfulness, meditation, and yoga help manage stress while potentially reducing symptom frequency through effects on the hypothalamic-pituitary-adrenal axis. Smoking accelerates oestrogen decline, worsens hot flashes, increases cardiovascular risk, and reduces bone density.[18] A woman who adds 150 minutes weekly of moderate exercise, shifts toward Mediterranean eating patterns, practices daily stress management, and quits smoking might find her symptoms improve substantially before adding pharmaceutical interventions. Prioritise lifestyle modifications as your first intervention, then layer treatments as needed.

Advocating for Comprehensive Care: Getting What You Need

Understanding Cardiovascular Risk Changes Everything

Heart disease kills more women than all cancers combined, and the menopausal transition accelerates cardiovascular risk more dramatically than most women or their doctors realise. The Study of Women’s Health Across the Nation (SWAN) documented rapid increases in LDL cholesterol, decreases in HDL cholesterol, elevated triglycerides, rising blood pressure, and progression toward metabolic syndrome during perimenopause—independent of chronological ageing.[19] These changes happen quickly. Research from the American College of Cardiology shows women’s cardiovascular health declines so rapidly after menopause that they quickly match men’s risk levels.[20] Women experiencing early menopause (before 45) face even higher risks of metabolic syndrome, insulin resistance, type 2 diabetes, and cardiovascular disease.[21] Yet many women and their healthcare providers focus exclusively on symptom management while ignoring these critical metabolic shifts. Consider a 51-year-old woman with moderate hot flashes, worsening cholesterol, rising blood pressure, and increasing abdominal fat: treating her vasomotor symptoms alone addresses quality of life but misses the cardiovascular emergency unfolding. The International Menopause Society now recommends routine “menopause checks” that screen for symptoms while also assessing cardiovascular and metabolic risk through early screening and lifestyle modification.[2] Request a comprehensive cardiovascular risk assessment during perimenopause, including lipid panels, blood pressure monitoring, glucose tolerance testing, and discussions about family history. Understand that treating menopausal symptoms and protecting cardiovascular health represent intertwined goals requiring integrated approaches.

Addressing Mental Health Deserves Equal Priority

Picture a 48-year-old woman leading a team of 30 people who suddenly experiences panic attacks before presentations. She’s promoted to partner at her law firm the same month she develops intrusive thoughts that terrify her. Society celebrates women ascending to leadership precisely when menopause destabilises their mental health-then penalises them for struggling. Depression, anxiety, intrusive thoughts, and suicidal ideation affect substantial numbers of women during the menopausal transition, yet mental health impacts receive far less attention than hot flashes. Women with a previous depression history face a heightened risk of depressive episodes during perimenopause, but the transition can trigger mood disorders even in women with zero mental health history.[22] Recent qualitative research reveals disturbing prevalence: “Many women reported feelings of dread, paranoia and intrusive thoughts, which could be suicidal in nature.” The mechanisms involve more than just hormone fluctuations. Oestrogen modulates serotonin, dopamine, and norepinephrine pathways; when levels drop and swing during perimenopause, neurotransmitter systems destabilise. Simultaneously, this life stage often coincides with caregiving responsibilities for ageing parents, launching adult children, career demands, relationship challenges, and existential reflection about ageing and mortality. Professor Marija Kundakovic, who leads groundbreaking research on menopause and mental health, notes: “This is something that needs more attention. It’s a very challenging period. Women are having so much to do generally in their family life… Then at work, a lot of women actually become leaders.”[24] A 47-year-old with decades of mental stability might suddenly develop severe anxiety and intrusive thoughts—symptoms she attributes to personal failing rather than recognising as menopause-related. The 2024 Lancet Series on Menopause calls for reduced stigma and approaches that empower women with high-quality information and empathic clinical care.[25] Discuss mental health symptoms explicitly with your healthcare provider, request screening for depression and anxiety, explore both pharmaceutical interventions (SSRIs/SNRIs, hormone therapy) and psychological approaches (CBT, mindfulness), and insist on treatment rather than accepting dismissals that symptoms represent “normal stress.”

Building Support Systems Strengthens Outcomes

Women consistently report feeling unheard, dismissed, and unsupported during the menopausal transition by healthcare providers, partners, families, and workplaces. When women say “I wish my partner were here to hear this,” they reveal profound needs for understanding and support that extend beyond medical interventions.[7] Partners who educate themselves about the menopausal transition, offer emotional support, adapt to changing sexual needs, and engage in dialogue about evolving relationship dynamics strengthen partnerships during this challenging period. Yet many partners dismiss symptoms as “just menopause” or hope difficulties will pass without intervention—responses that damage relationships and impede help-seeking. Similarly, women need healthcare providers who stay current on evolving evidence, take symptoms seriously, offer comprehensive treatment options, and support patient autonomy in treatment decisions. Dr Molero Rodríguez emphasises: “You are entitled to be listened to and get information not only on treatments for symptoms, but also on the psychological and related changes.”[7] Workplace accommodations matter too: flexible scheduling during severe symptom periods, temperature control options, understanding from supervisors about medical appointments, and cultures that allow discussion of menopause without stigma. Consider a woman whose severe symptoms affect work performance: without supportive systems, she might suffer silently, experiencing diminished productivity, professional setbacks, and eroded self-confidence. With support—a partner who attends appointments, a doctor who explores all options, a workplace that accommodates needs—she maintains function while addressing symptoms effectively. Take concrete steps to build support: educate your partner about menopause using reliable resources, seek healthcare providers specialising in menopause care, discuss workplace accommodations with HR or supervisors, and connect with other women navigating this transition through support groups or online communities. The International Menopause Society envisions a future where all women worldwide have equitable access to evidence-based knowledge and care, empowering fully informed midlife health choices.[2]

Menopause happens naturally to 1.3 billion women worldwide, yet approaches vary dramatically based on access to information, quality healthcare, and support systems. You deserve comprehensive care addressing physical symptoms, cardiovascular risk, mental health, and quality of life through personalised combinations of lifestyle modifications, evidence-based treatments, and robust support.

The November 2025 FDA guidance update, emerging cardiovascular research, and expanded treatment options create unprecedented opportunities to navigate menopause successfully. Suffering through symptoms remains unnecessary when effective interventions exist. Educate yourself thoroughly, then advocate persistently for care. Seek healthcare providers who stay current on evidence, listen to concerns, and support your treatment preferences. Build support through partners, friends, family, and communities. Monitor cardiovascular and metabolic health proactively. Address mental health symptoms directly and insist on treatment.

The menopausal transition can become a period of growth, self-knowledge, and empowerment when women receive adequate support. Your symptoms deserve attention, your concerns deserve validation, and your quality of life matters profoundly.

Go Further: Essential Resources

Find a Menopause Specialist:

• The Menopause Society Provider Directory — Search for NAMS-certified practitioners near you
• British Menopause Society Specialist Database — UK-based menopause specialists
• International Menopause Society Member Directory — Global expert network

Trusted Medical Information:

• Study of Women’s Health Across the Nation (SWAN) — Landmark research tracking women through menopause
• FDA Menopause Guidance Updates — Official regulatory information on hormone therapy
• The Lancet Series on Menopause (2024) — Comprehensive scientific review

Support and Advocacy:

• The Menopause Charity — Education, support groups, workplace resources
• North American Menopause Society — Patient education materials

Frequently Asked Questions

At what age does menopause typically start?

The average age for menopause onset is 51, but perimenopause typically begins in your 40s (ages 45-55 for most women). Early menopause (before 45) affects about 5% of women. Surgical menopause occurs immediately after ovary removal regardless of age.

How long do menopause symptoms last?

Perimenopause lasts 4-8 years on average. Hot flashes typically persist 7-10 years, though some women experience them for over a decade. Genitourinary symptoms worsen over time without treatment rather than resolving spontaneously.

Is hormone therapy safe now that the FDA removed black box warnings?

Hormone therapy proves safe and effective when started within 10 years of menopause onset or before age 60. The November 2025 FDA guidance corrects 23 years of misleading warnings. Timing matters: benefits outweigh risks during this window; the risk-benefit profile changes for women starting therapy many years past menopause.

What treatments work if I can’t take hormones?

SSRIs, SNRIs, and gabapentin reduce hot flashes by 50-60%. Cognitive behavioural therapy addresses symptom distress effectively. Evidence-based botanicals like black cohosh show promise. Hyaluronic acid vaginal moisturisers achieve 80-87% efficacy for genitourinary symptoms. Lifestyle modifications (exercise, Mediterranean diet, stress management) form the foundation.

Will menopause affect my heart health?

Yes, significantly. The menopausal transition accelerates cardiovascular risk through rapid changes in cholesterol, blood pressure, and metabolic markers independent of ageing. Heart disease kills more women than all cancers combined. Request comprehensive cardiovascular screening during perimenopause, including lipid panels, blood pressure monitoring, and glucose testing.

Can menopause cause depression and anxiety?

Yes. Oestrogen modulates neurotransmitter systems; fluctuating levels during perimenopause destabilise mood regulation. Women experience heightened risk of depression, anxiety, and intrusive thoughts even without a previous mental health history. These symptoms deserve treatment, not dismissal as “normal stress.”

Why am I experiencing brain fog?

Oestrogen receptors populate brain regions governing memory and attention. Fluctuating oestrogen during perimenopause temporarily destabilises these neural systems, causing memory lapses, concentration difficulties, and word-finding problems. Cognitive function typically returns to baseline post-menopause once hormones stabilise.

Should I treat vaginal dryness even if I’m not sexually active?

Yes. Genitourinary syndrome affects more than sexual function: urinary urgency, recurrent infections, tissue thinning, and daily discomfort worsen without treatment. Local oestrogen and hyaluronic acid moisturisers work effectively. Treatment proves more successful when initiated proactively before tissue changes become severe.

Does hormone therapy increase dementia risk?

No. Recent WHO-commissioned research confirms menopausal hormone therapy carries no increased dementia risk. This addresses longstanding fears and provides reassurance for women considering treatment.

What’s the difference between perimenopause and menopause?

Perimenopause is the transition period (4-8 years) when hormones fluctuate wildly and symptoms occur. Menopause is the single point 12 months after your final period. Post-menopause refers to all years following menopause. Most symptoms occur during perimenopause.

Can lifestyle changes really make a difference?

Yes, substantially. Exercise reduces hot flash frequency, supports bone density, protects cardiovascular health, and improves mood. Mediterranean dietary patterns reduce cardiovascular risk precisely when menopause accelerates it. Stress management techniques affect the hypothalamic-pituitary-adrenal axis, potentially reducing symptom frequency. Smoking cessation improves every menopause-related health outcome.

How do I find a doctor who takes menopause seriously?

Seek NAMS-certified menopause practitioners through The Menopause Society directory. Ask potential providers: “What percentage of your practice focuses on menopause care?” and “Do you stay current on evolving menopause research?” Consider switching providers if yours dismisses symptoms or relies on outdated guidance.

Will I gain weight during menopause?

Metabolic changes during menopause increase the tendency toward abdominal fat accumulation and make weight management more challenging. However, weight gain remains preventable through consistent exercise, Mediterranean dietary patterns, and strength training to maintain muscle mass. Address it through lifestyle modifications rather than accepting it as inevitable.

Can I still get pregnant during perimenopause?

Yes. Hormone levels fluctuate during perimenopause, meaning ovulation still occurs unpredictably. Continue contraception until 12 months after your final period (if over 50) or 24 months (if under 50) if pregnancy prevention matters to you.

What blood tests diagnose menopause?

Doctors typically diagnose menopause based on symptoms and menstrual patterns rather than blood tests. FSH (follicle-stimulating hormone) tests show limited value because levels fluctuate dramatically during perimenopause. Focus conversations on symptom management and health screening rather than pursuing definitive diagnostic tests.

About This Article

Written by Haider Alleg — 20+ years women’s health expertise | Former pharmaceutical executive specialising in women’s health product launches, including Vagifem10, eviana, Esmya, Lisvy, Ferring Fertility portfolio, and Galinea

Medically reviewed by Dr. Elke Bestel, MD — Gynaecologist with 25+ years experience in women’s health | Trained in gynaecology and obstetrics in Switzerland | Former Chief Medical Officer at ObsEva and PregLem, leading clinical development programmes for Esmya® and Yselty® for uterine fibroids and endometriosis

Last updated: 11 January 2026

Sources

This article references 25+ peer-reviewed studies, clinical guidelines from major medical organisations (FDA, WHO, American Heart Association, The Menopause Society, American Urological Association), and interviews with leading menopause specialists. All claims are substantiated with primary sources linked throughout the text.

Key Medical Organisations Cited: U.S. Food and Drug Administration (FDA) | World Health Organisation (WHO) | The Menopause Society (formerly North American Menopause Society) | American Heart Association | American Urological Association | British Menopause Society | International Menopause Society | Spanish Menopause Society | Study of Women’s Health Across the Nation (SWAN)

Expert Contributors: Dr. Francisca Molero Rodríguez, Director, Iberoamerican Institute of Sexology | Dr. Stephanie Faubion, Medical Director, The Menopause Society | Dr. Alicia Jackson, Chief Medical Officer, ARPA-H | Prof. Marija Kundakovic, Associate Professor, Fordham University (menopause-mental health research)

Medical Disclaimer

This article provides general information about menopause and should not replace professional medical advice. Always consult qualified healthcare providers for personalised diagnosis and treatment recommendations. If you experience severe symptoms, suicidal thoughts, or medical emergencies, seek immediate medical attention.

Conflict of Interest: This article contains no sponsored content. The author and reviewer have no financial relationships with pharmaceutical companies or medical device manufacturers.

Content Standards: This article adheres to prettywell.org‘s editorial guidelines requiring peer-reviewed sources, medical expert review, and regular updates to reflect current clinical evidence.

References

1. PMC. (2024). The menopausal transition is a period of significant hormonal and psychosocial change. https://pmc.ncbi.nlm.nih.gov/articles/PMC12237151/
2. International Menopause Society. (2024). Climacteric: The Journal of the International Menopause Society. https://www.tandfonline.com/doi/full/10.1080/13697137.2024.2394950
3. American Heart Association. Menopause Transition and Cardiovascular Disease Risk. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000912
4. The Lancet Healthy Longevity. (2025). Brain changes during the menopausal transition. https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(25)00122-9/fulltext
5. ScienceAlert. Menopause Hormone Therapy Is Not Linked to Dementia Risk, Review Suggests. https://www.sciencealert.com/menopause-hormone-therapy-is-not-linked-to-dementia-risk-review-suggests
6. Oxford Academic. (2024). Genitourinary syndrome of menopause: prevalence and treatment. https://academic.oup.com/smr/article/14/1/qeaf055/8261468
7. Menopausia Care. Understanding Menopause and Sexual Health. https://menopausia.care/en/menopausia-en/
8. Menopausia Care. Scientific Evidence for Menopause Treatments. https://menopausia.care/en/cientifics-evidency/
9. U.S. Food and Drug Administration. (2025). HHS Advances Women’s Health, Removes Misleading FDA Warnings from Hormone Replacement Therapy. https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy
10. JAMA. Women’s Health Initiative hormone therapy trials. https://jamanetwork.com/journals/jama/fullarticle/2841321
11. U.S. Department of Health and Human Services. Fact Sheet: FDA Initiates Removal of Black Box Warnings from Menopausal Hormone Replacement Therapy Products. https://www.hhs.gov/press-room/fact-sheet-fda-initiates-removal-of-black-box-warnings-from-menopausal-hormone-replacement-therapy-products.html
12. The Menopause Society. When Women Initiate Estrogen Therapy Matters. https://menopause.org/press-releases/when-women-initiate-estrogen-therapy-matters
13. British Menopause Society. (2025). Non-hormonal Based Treatments for Menopausal Symptoms: BMS Consensus Statement. https://thebms.org.uk/wp-content/uploads/2025/11/04-BMS-ConsensusStatement-Non-hormonal-based-treatments-for-menopausal-symptoms-NOV2025-C.pdf
14. Menopausia Care. Libimeno: Evidence-based botanical treatments. https://menopausia.care/en/libimeno/
15. Menopausia Care. Menocare: Treatment options for menopause. https://menopausia.care/en/menocare-en/
16. Urology Times. (2025). From GSM Guidance to HRT Reform: A Landmark Year for Women’s Health. https://www.urologytimes.com/view/from-gsm-guidance-to-hrt-reform-a-landmark-year-for-women-s-health
17. PMC. Physical Activity and Exercise for Menopausal Symptoms. https://pmc.ncbi.nlm.nih.gov/articles/PMC6074805/
18. PMC. Smoking and Menopause: Effects on Hormones and Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC10074318/
19. Study of Women’s Health Across the Nation (SWAN). Cardiovascular Risk and Heart Health in Women During and After Menopause. https://www.swanstudy.org/womens-health-info/cardiovascular-risk-and-heart-health-in-women-during-and-after-menopause/
20. American College of Cardiology. (2024). Heart Health Declines Rapidly After Menopause. https://www.acc.org/About-ACC/Press-Releases/2024/04/01/21/39/heart-health-declines-rapidly-after-menopause
21. The Menopause Society. Early Natural Menopause Linked with Higher Risk of Metabolic Syndrome. https://menopause.org/press-releases/early-natural-menopause-linked-with-higher-risk-of-metabolic-syndrome
22. Study of Women’s Health Across the Nation (SWAN). Depression and Menopause. https://www.swanstudy.org/womens-health-info/depression-menopause/
23. Qualitative research on menopause mental health symptoms. (2024). Multiple studies document prevalence of intrusive thoughts and suicidal ideation during menopausal transition.
24. Fordham University. Professor Leads Groundbreaking Study on Menopause-Mental Health Connection. https://now.fordham.edu/university-news/professor-leads-groundbreaking-study-on-menopause-mental-health-connection/
25. The Lancet Series on Menopause. (2024). Reducing stigma and empowering women with evidence-based menopause care.